Stock listing

Genedrive Plc

Selected listing: D6M · FWB · EUR · DE

Genedrive Plc (Frankfurt:D6M), Health Technology. Latest release Sep 10, 2026: Welsh hospitals extend routine MT-RNR1 testing.

D6M:FWBEURDEUpdated October 3, 2026
Genedrive Plc logo
Ticker
Frankfurt:D6M
Asset type
Stock
Sector
Health Technology
Industry
Medical Specialties
Exchange
Frankfurt
Currency
EUR

About Genedrive Plc

The company focuses on developing innovative molecular diagnostics for various medical applications. Genedrive aims to improve patient outcomes through its advanced technology and product offerings.

Latest news from Genedrive Plc

Welsh hospitals extend routine MT-RNR1 testing

September 10, 2026

ShareSoc Investor Presentation Reminder

September 3, 2026

Director/PDMR Notification

September 1, 2026

Board Appointments

August 21, 2026

ShareSoc Investor Presentation

August 13, 2026

All Genedrive Plc news →

Events

Replays

  • GENEDRIVE PLC (GDR) — Full year results briefing

    Mon, Dec 08, 2025 · 09:00 AM ET

    Watch

  • GENEDRIVE PLC (GDR) — Full year results briefing

    Mon, Dec 02, 2024 · 09:00 AM ET

    Watch

  • GENEDRIVE PLC (GDR) — Interim results presentation

    Fri, Apr 05, 2024 · 05:00 AM ET

    Watch

Research Genedrive Plc

Genedrive Plc company profile

View the public company page for Genedrive Plc on 6ix.

Genedrive Plc news

Read company news and market updates connected to Genedrive Plc.

Genedrive Plc investor events

Find investor webinars, events, and replay context for Genedrive Plc.

Alternate listings

GDR:LSE

GB · GBX

Alternate listing for Genedrive Plc; the primary context on this page is D6M:FWB.

GDRL:AQUISUK

GB · GBX

Alternate listing for Genedrive Plc; the primary context on this page is D6M:FWB.

D6M:SWB

DE · EUR

Alternate listing for Genedrive Plc; the primary context on this page is D6M:FWB.